Cost-Effectiveness of Apixaban vs. Current Standard of Care for Stroke Prevention in Patients With Atrial Fibrillation

Study Questions:

What is the potential cost-effectiveness of apixaban against warfarin and aspirin for stroke prevention in patients with atrial fibrillation (AF) from the UK payer perspective?